Pfizer posts 65.7 pc rise in net profit to Rs 313 cr in Sept quarter

New Delhi, Nov 3 (PTI) Drugmaker Pfizer Ltd on Tuesday reported a 65.72 per cent increase in net profit to Rs 313.25 crore in the September quarter, driven by gains from exceptional items.

The company had posted a profit of Rs 189 crore in the corresponding period of the previous fiscal year, Pfizer said in a regulatory filing.

Pfizer has accounted for exceptional gains of Rs 132.06 crore in the September quarter from its parent entity Pfizer Inc USA following the sale of Minipress XL. Consequent to the decision, Pfizer Ltd discontinued the manufacture of Minipress XL from September 7, 2026, according to the filing.

Its profit before tax and exceptional items stood at Rs 290.77 crore during the quarter under review, up 13.86 per cent year-on-year.

It was at Rs 255.37 crore in the corresponding quarter of the previous fiscal year.

Its total income rose to Rs 774.19 crore during the quarter under review from Rs 684.19 crore in the year-ago period.

Pfizer reported an increase in total expenses to Rs 483.2 crore in the September quarter from Rs 428.82 crore a year ago.

In the half-yearly period ending September 2026, the company posted a net profit of Rs 517.72 crore. Its net profit in the April-September period in FY26 stood at Rs 380.77 crore.

Shares of Pfizer closed 3.37 per cent higher at Rs 3,760.5 apiece on the BSE. PTI TRB SHM